<DOC>
	<DOCNO>NCT02938182</DOCNO>
	<brief_summary>The underlie mechanisms association right-to-left shunt ( RLS ) migraine may concern platelet aggregation paradoxical embolization . The aim study evaluate prophylactic effectiveness clopidogrel migraineurs RLS .</brief_summary>
	<brief_title>Migraine Prophylaxis With Clopidogrel Trial</brief_title>
	<detailed_description>Many study show increased prevalence right-to-left shunt migraineurs . The underlie mechanisms association right-to-left shunt ( RLS ) migraine may concern platelet aggregation paradoxical embolization . In present study , migraineurs without take prophylactic medicine regularly give clopidogrel 75 mg daily three month . Migraineurs unresponsive least two commonly apply preventive medication , clopidogrel 75 mg daily add his/her exist prophylactic migraine regimen three month . Patients follow third month sixth month headache frequency , attack duration headache , migraine disability assessment scale（MIDAS）scores , headache impact test（HIT-6）scores visual analogue scale（VAS）scores . Investigators evaluate change measurement baseline follow-up time . The aim study evaluate prophylactic effectiveness clopidogrel migraineurs RLS .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>migraine without aura diagnose neurologist accord criterion International Headache Society ( 3nd edition ) experience minimum two migraine attack per month 3month baseline phase without regular use prophylactic treatment unresponsive two commonly apply preventive medication presence RLS confirm contrastenhanced transcranial Doppler positive finding cranial CT MRI type headache systemic chronic disease , cerebrovascular disease , abnormal platelet liver function history head injury contraindication clopidogrel treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>